Evolus, Inc.
(NASDAQ : EOLS)

( )
EOLS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
-0.40%42.160.9%$944.32m
JNJJohnson & Johnson
-1.14%135.320.6%$831.62m
MRKMerck & Co., Inc.
-1.43%69.170.6%$633.99m
ABBVAbbVie, Inc.
0.10%97.732.1%$629.84m
LLYEli Lilly and Company
-0.69%105.091.0%$472.84m
BMYBristol-Myers Squibb Company
-0.41%60.071.4%$402.76m
AZNAstraZeneca PLC Sponsored ADR
-0.23%38.761.3%$188.11m
NVSNovartis AG Sponsored ADR
0.29%83.800.2%$141.82m
GSKGlaxoSmithKline plc Sponsored ADR
0.41%41.500.2%$114.74m
SNYSanofi Sponsored ADR
1.52%42.860.2%$100.50m
NVONovo Nordisk A/S Sponsored ADR Class B
2.01%49.180.1%$76.18m
LCILannett Company, Inc.
5.61%5.6537.9%$9.29m
AKTXAkari Therapeutics Plc Sponsored ADR
-1.56%1.891.7%$0.05m
EPIXESSA Pharma Inc
4.26%3.180.0%$0.01m

Company Profile

Evolus, Inc. is a medical aesthetics company. The company is engaged in providing physicians and patients with expanded choices in aesthetic procedures and treatments. Evolus was founded in November, 2012 and is headquartered in Irvine, CA.